A lot of attention has historically been paid to CareFusion Corporation (NYSE: CFN ) in the context of its place in the infusion pump oligopoly with Baxter (NYSE: BAX ) and Hospira (NYSE: HSP )
. There is a lot more to this story, though, as the company is a leader
in medication dispensing, pre-op skin prep, and respiratory care. The
acquisition of Vital Signs from General Electric will
add scale in respiratory care and anesthesia, but leaves the company
with enough dry powder to continue making additive deals. CareFusion is
not a slam-dunk bargain, and there aren't many of those left in
med-tech, but it is a name worth consideration today or at least a spot
on investor watchlists.
Please continue here:
CareFusion Corporation: A Mid-Cap Med-Tech Leader
No comments:
Post a Comment